Trial Under News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EDVA Permits Plaintiff to Use Her Deposition as Trial Testimony | Troutman Pepper

It is not uncommon in litigation for parties to introduce testimony through depositions taken for use at trial. It is very uncommon, though, for a party to request to use their own.

United statesDavid novakTruth tellersWashington national airportScope of the court discretionCourt discretion to exclude deposition testimonyChrysler intl corpAirlines incA court mayAirport authCivil actionSusan glassWashington nationalConduct de bene esse depositionsDeposition testimonyTrial under

NeuroSense Announces Second Quarter 2023 Financial Results and Provides Business Update

ALS Phase 2b PARADIGM Trial Completed Patient EnrollmentTopline results expected in Q-4 2023Cash runway beyond topline clinical study readouts, into Q-2 2024CAMBRIDGE, Mass., Aug. 16, 2023. -Today at 09:01 am- MarketScreener

United kingdomNeurosense therapeutics ltdPrnewswire neurosense therapeutics ltdExchange commissionCompleted patientSense therapeuticsAmyotrophic lateral sclerosisScientific agreementTrial underBiomarker studyBiomarkers summitMonths ended juneInterim unaudited statementsCash flowsNeurosense therapeuticAnnual report

NeuroSense CEO Provides Q2 2023 Update

NeuroSense CEO Provides Q2 2023 Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomNeurosense therapeutics ltdExchange commissionPrnewswire neurosense therapeutics ltdSense therapeuticsAmyotrophic lateral sclerosisCompleted patient enrollmentScientific agreementTrial underBiomarker study completedNeurosense therapeuticAnnual reportNeurosense therapeutics

NeuroSense CEO Provides Q1 2023 Update: Phase 2b ALS Trial Achieves 80% Enrollment

/PRNewswire/ NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.

United statesUnited kingdomPrnewswire neurosense therapeutics ltdNeurosense therapeutics ltdHospital neuroepigenetics labSense therapeuticsAlon ben noonAmyotrophic lateral sclerosisPatient enrollmentTrial underBiomarker study completedMassachusetts general hospitalNeuroepigenetics lab

Mettmann: Streit zwischen Vater und Sohn landet vor Gericht

Mettmann: Streit zwischen Vater und Sohn landet vor Gericht
rp-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rp-online.de Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenBritta pedersenSon in courtMettmanner family in courtDistrict courtHas negotiated with the district courtSon endsMettmanner familyTrial underHad exchangedNegotiated withProcedures haveFather hadThe meantimeDistrict court wouldThe end it was